Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Zuki Inc (ZUKI)

Zuki Inc (ZUKI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
3 Web 3.0 Stocks to Consider Before Next Bull Market Run Spotlight Growth - Thu Aug 18, 2022

The emergence of the third generation of web technologies, or Web 3.0, means our lives are once again in the

META : 554.40 (+0.06%)
RBLX : 51.03 (+0.59%)
NVDA : 140.15 (-1.29%)
ZUKI : 0.0739 (-4.77%)
GMER : 0.0095 (unch)
NFTFF : 0.0066 (+73.68%)
Blockchain Gaming is Dominating VC Deal Making in 2022 Spotlight Growth - Tue Jul 5, 2022

Crypto might appear to be in freefall right now, but blockchain gaming is dominating VC deal-making in 2022. Roblox (NASDAQ:

RBLX : 51.03 (+0.59%)
ZUKI : 0.0739 (-4.77%)
LUSI : 0.2085 (+22.65%)

Barchart Exclusives

Buy This Pharma Stock to Bet on the Next Blockbuster Weight-Loss Drug Barchart - 7 minutes ago
A shocking study in The Lancet showed that nearly three-quarters of U.S. adults are overweight or obese. Chances are that by 2050, there will be 260 million overweight Americans. We already have GLP-1 drugs, and amylin-based drugs are next. Novo Nordisk's compound, Cagrilintide, will be combined with semaglutide in its next blockbuster drug, CagriSema. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot